Skip to content
Politically.com Search all
Menu

S 2531 119th Congress

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

A bill to authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes.

Official Title as Introduced Congress.gov

Introduced Jul 30, 2025 Latest action Mar 19, 2026 Sponsor: Sen. Alsobrooks, Angela D. [D-MD] Health
Open official Congress.gov record
Source: Congress.govUpdated 2026-09-17 15:09:16 UTC.

Source-linked procedural record

Bill journey

5 dated records

This is a chronology, not a progress score. Politically.com does not classify stages or infer what comes next. Records sharing a date are grouped because not every source field supplies a time.

Congress.gov Recently refreshed U.S. Senate XML Recently refreshed
Introduction 1 One supplied introduction date.
Official actions 3 3 dated action records.
Committees 1 1 undated relationship.
Amendments 0 No record is cached.
Text versions 1 1 dated, 0 without a supplied date.
House roll calls 0 No exact legislation-key match in the House-vote cache.
Senate roll calls 0 No exact document-key match in the Senate-vote cache.
Related measures 0 No related-measure relationship is cached.
Linked law 0 No linked law record is cached; this does not predict outcome.
  1. Official action Congress.gov

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    IntroReferral · Senate

    Open bill record

    Official action Congress.gov

    Introduced in Senate

    IntroReferral · Library of Congress · Code 10000

    Open bill record

    Text version Congress.gov

    Introduced in Senate

    A dated text-version record is available.

    Open text record
  2. Official action Congress.gov

    Committee on Health, Education, Labor, and Pensions. Hearings held.

    Committee · Senate

    Open bill record
View the complete bill journey as an accessible table
Every dated cached record linked to S 2531. Same-date row order does not assert procedural sequence.
Date and timeRecordOfficial detailSource
IntroductionIntroduced Introduced in the Senate. Congress.gov
Official actionRead twice and referred to the Committee on Health, Education, Labor, and Pensions. No additional detail supplied.IntroReferral · Senate Congress.gov
Official actionIntroduced in Senate No additional detail supplied.IntroReferral · Library of Congress · Code 10000 Congress.gov
Text versionIntroduced in Senate A dated text-version record is available. Congress.gov
Official actionCommittee on Health, Education, Labor, and Pensions. Hearings held. No additional detail supplied.Committee · Senate Congress.gov

House roll calls join only on matching Congress, legislation type, and number. Senate roll calls join only on matching source-supplied document type and number, not question text. Committee and related-measure relationships have no date in their relationship records and therefore are counted above but never placed on the chronology.

Congressional Research Service

CRS summary

Introduced in Senate Jul 30, 2025

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025This bill authorizes grants to support early detection of and intervention for uterine fibroids. Uterine fibroids are tumors in the wall of the uterus that are usually benign but can cause painful and heavy menstrual bleeding and other symptoms.The bill requires the Department of Health and Human Services (HHS) to (1) conduct or support research on increasing early detection of and medical intervention for uterine fibroids, and (2) formulate strategies to increase early detection based on such research. Also, the bill authorizes HHS to provide grants to states to increase early detection of and intervention for uterine fibroids (e.g., screenings) and to carry out public awareness campaigns. Additionally, the bill authorizes HHS to provide grants to states for research relating to (1) disparities in pain management in uterine fibroid surgical treatment; or (2) uterine health conditions, as determined appropriate by HHS.HHS must report to Congress every two years on the activities funded by grants under the bill, including findings from the research conducted by states.

Official documents

Text versions